DE69726206D1 - Prodrogen von 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-on - Google Patents
Prodrogen von 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-onInfo
- Publication number
- DE69726206D1 DE69726206D1 DE69726206T DE69726206T DE69726206D1 DE 69726206 D1 DE69726206 D1 DE 69726206D1 DE 69726206 T DE69726206 T DE 69726206T DE 69726206 T DE69726206 T DE 69726206T DE 69726206 D1 DE69726206 D1 DE 69726206D1
- Authority
- DE
- Germany
- Prior art keywords
- benzisothiazol
- indol
- prodrugs
- piperazinyl
- dihydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11568 | 1993-02-01 | ||
US1156896P | 1996-02-13 | 1996-02-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69726206D1 true DE69726206D1 (de) | 2003-12-24 |
DE69726206T2 DE69726206T2 (de) | 2004-04-15 |
Family
ID=21750970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69726206T Expired - Fee Related DE69726206T2 (de) | 1996-02-13 | 1997-01-21 | Prodrogen von 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-on |
Country Status (10)
Country | Link |
---|---|
US (1) | US5935960A (de) |
EP (1) | EP0790236B1 (de) |
JP (1) | JP2911032B2 (de) |
AT (1) | ATE254600T1 (de) |
CA (1) | CA2197272C (de) |
DE (1) | DE69726206T2 (de) |
DK (1) | DK0790236T3 (de) |
ES (1) | ES2210450T3 (de) |
MX (1) | MX9701116A (de) |
PT (1) | PT790236E (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE254600T1 (de) * | 1996-02-13 | 2003-12-15 | Pfizer | Prodrogen von 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl ethyl)-6-chloro-1,3-dihydro-2h-indol- 2-on |
IL127497A (en) * | 1997-12-18 | 2002-07-25 | Pfizer Prod Inc | Medicinal products containing piperazinyl-heterocyclic compounds for the treatment of psychiatric disorders |
US6150366A (en) * | 1998-06-15 | 2000-11-21 | Pfizer Inc. | Ziprasidone formulations |
US6616270B1 (en) | 1998-08-21 | 2003-09-09 | Seiko Epson Corporation | Ink jet recording head and ink jet recording apparatus comprising the same |
US7030142B1 (en) | 1999-04-06 | 2006-04-18 | Sepracor Inc. | Methods for the treatment of neuroleptic and related disorders using ziprasidone metabolites |
AU4062900A (en) * | 1999-04-06 | 2000-10-23 | Sepracor, Inc. | Methods and compositions for the treatment of neuroleptic and related disorders using ziprasidone metabolites |
BR0315516A (pt) | 2002-10-24 | 2005-08-23 | Pfizer Prod Inc | Derivados de acila de 5-(2-(4-(1,2-benzoisotiazol-3-il)-1-piperazinil)etil)-6-clo ro-1,3-dihidro-2h-indol-2-ona tendo atividade neuroléptica |
CA2467538C (en) * | 2004-05-14 | 2010-08-24 | Apotex Pharmachem Inc. | New amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride) and processes to produce the same |
CA2471219A1 (en) * | 2004-06-14 | 2005-12-14 | Apotex Pharmachem Inc. | Improved preparation of an anhydrate form of 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride (ziprasidone hydrochloride) |
CA2500667C (en) * | 2005-03-11 | 2013-01-15 | Apotex Pharmachem Inc. | Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactions |
MX2009011681A (es) * | 2007-05-18 | 2009-11-10 | Scidose Llc | Formulaciones de ziprasidona. |
PL391810A1 (pl) | 2010-07-14 | 2012-01-16 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Nowe sole ziprasidonu oraz sposoby ich otrzymywania |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4831031A (en) * | 1988-01-22 | 1989-05-16 | Pfizer Inc. | Aryl piperazinyl-(C2 or C4) alkylene heterocyclic compounds having neuroleptic activity |
US5077295A (en) * | 1988-09-16 | 1991-12-31 | Pfizer Inc. | Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides |
US5087627A (en) * | 1989-03-15 | 1992-02-11 | Santen Pharmaceutical Co., Ltd. | Agent for treatment of disorders of the cerebro-neural transmission system |
US5312925A (en) * | 1992-09-01 | 1994-05-17 | Pfizer Inc. | Monohydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one-hydrochloride |
US5359068A (en) * | 1993-06-28 | 1994-10-25 | Pfizer Inc. | Processes and intermediates for the preparation of 5-[2-(4-(benzoisothiazol-3-yl)-piperazin-1-yl)ethyl]-6-chloro-1,3-dihydro-indol-2-one |
ATE254600T1 (de) * | 1996-02-13 | 2003-12-15 | Pfizer | Prodrogen von 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl ethyl)-6-chloro-1,3-dihydro-2h-indol- 2-on |
-
1997
- 1997-01-21 AT AT97200175T patent/ATE254600T1/de not_active IP Right Cessation
- 1997-01-21 ES ES97200175T patent/ES2210450T3/es not_active Expired - Lifetime
- 1997-01-21 DE DE69726206T patent/DE69726206T2/de not_active Expired - Fee Related
- 1997-01-21 PT PT97200175T patent/PT790236E/pt unknown
- 1997-01-21 DK DK97200175T patent/DK0790236T3/da active
- 1997-01-21 EP EP97200175A patent/EP0790236B1/de not_active Expired - Lifetime
- 1997-02-07 US US08/798,395 patent/US5935960A/en not_active Expired - Fee Related
- 1997-02-11 CA CA002197272A patent/CA2197272C/en not_active Expired - Fee Related
- 1997-02-12 MX MX9701116A patent/MX9701116A/es unknown
- 1997-02-13 JP JP9028993A patent/JP2911032B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2911032B2 (ja) | 1999-06-23 |
CA2197272C (en) | 2001-01-23 |
DK0790236T3 (da) | 2004-02-23 |
CA2197272A1 (en) | 1997-08-14 |
EP0790236B1 (de) | 2003-11-19 |
US5935960A (en) | 1999-08-10 |
ATE254600T1 (de) | 2003-12-15 |
DE69726206T2 (de) | 2004-04-15 |
JPH09227516A (ja) | 1997-09-02 |
MX9701116A (es) | 1998-04-30 |
EP0790236A1 (de) | 1997-08-20 |
ES2210450T3 (es) | 2004-07-01 |
PT790236E (pt) | 2004-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY119997A (en) | Mesylate dihydrate salts of 5-(2-(4-(1, 2-benzisothiazol-3-yl) -1-piperazinyl)-6-chloro-1, 3- dihydro-2h-indol-2-one | |
NO933093L (no) | Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2H-indol-2-on hydroklorid | |
TW427989B (en) | Mesylate trihydrate of 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one | |
RU93043528A (ru) | Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения | |
DE60110262D1 (de) | Thiazol und oxazol-derivate als aktivatoren von menschlichen peroxisom proliferator aktivierten rezeptoren | |
DE69726206D1 (de) | Prodrogen von 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-on | |
NO924696D0 (no) | Fremgangsmaate for fremstilling av oksazolidinon- og tiazolidinon-derivater | |
NO305082B1 (no) | 2-(4-(4-azolbutyl)-1-piperazinyl)-5-hydroksy-pyrimidinderivater, deres fremstilling og anvendelse som legemidler | |
ATE337313T1 (de) | 5-4'-2'-(n-methyl-n-(2-pyridyl)amino) ethoxy)benzyl)thiazolidin-2,4-dion mesylatsalz | |
PT1446404E (pt) | Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos | |
HUP0003463A2 (hu) | Piperidinil-metil-oxazolidinon-származék, eljárás ennek előállítására és a vegyületet tartalmazó gyógyszerkészítmény | |
GB0021784D0 (en) | Novel pharmaceutical | |
MY109504A (en) | Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2- one hydrochloride | |
ECSP972089A (es) | Sal mesilato trihidrato de 5-[2-[4(1,2-benzoisotiazol-3-il]-1-piperazinil)etil]-6-cloro- 1,3- dihidro- 2h- inddol - 2 - ona | |
HUP9902404A2 (hu) | 5-(2-(4-(1,2-Benzizotiazol-3-il)-1-piperazinil)-etil)-6-klór-1,3-dihidro-2-(2H)-indol-2-on (ziprazidon) mezilát-dihidrát sói, a vegyületek előállitása és dopamin D2 antagonistaként történő alkalmazása |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |